vs
Ensysce Biosciences, Inc.（ENSC）与KOSS CORP（KOSS）财务数据对比。点击上方公司名可切换其他公司
KOSS CORP的季度营收约是Ensysce Biosciences, Inc.的1.5倍（$2.9M vs $1.9M），KOSS CORP净利率更高（-19.8% vs -147.0%，领先127.3%），Ensysce Biosciences, Inc.同比增速更快（44.4% vs -19.6%），过去两年Ensysce Biosciences, Inc.的营收复合增速更高（107.9% vs 4.2%）
Ensysce Biosciences是一家临床阶段生物技术公司，专注于开发疼痛管理和肿瘤适应症领域的创新前药疗法，其专有平台可降低阿片类药物滥用风险并提升治疗有效性，面向全球医疗医药市场，重点解决未被满足的临床需求。
高斯公司是一家总部位于美国威斯康星州密尔沃基的耳机生产企业，1958年推出了全球首款高保真立体声耳机，在音频耳机领域拥有深厚的技术积累与悠久的发展历史。
ENSC vs KOSS — 直观对比
营收规模更大
KOSS
是对方的1.5倍
$1.9M
营收增速更快
ENSC
高出63.9%
-19.6%
净利率更高
KOSS
高出127.3%
-147.0%
两年增速更快
ENSC
近两年复合增速
4.2%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9M | $2.9M |
| 净利润 | $-2.8M | $-565.4K |
| 毛利率 | — | 29.0% |
| 营业利润率 | -147.8% | -35.5% |
| 净利率 | -147.0% | -19.8% |
| 营收同比 | 44.4% | -19.6% |
| 净利润同比 | 22.3% | -700.6% |
| 每股收益（稀释后） | $-0.51 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENSCKOSS
| Q4 25 | $1.9M | $2.9M | ||
| Q3 25 | $493.1K | $4.1M | ||
| Q2 25 | $1.4M | $3.1M | ||
| Q1 25 | $1.3M | $2.8M | ||
| Q4 24 | $1.3M | $3.6M | ||
| Q3 24 | $3.4M | $3.2M | ||
| Q2 24 | — | $2.9M | ||
| Q1 24 | — | $2.6M |
净利润ENSCKOSS
| Q4 25 | $-2.8M | $-565.4K | ||
| Q3 25 | $-3.7M | $243.7K | ||
| Q2 25 | $-1.7M | $-232.7K | ||
| Q1 25 | $-1.9M | $-316.7K | ||
| Q4 24 | $-3.6M | $94.1K | ||
| Q3 24 | $661.8K | $-419.5K | ||
| Q2 24 | — | $-110.4K | ||
| Q1 24 | — | $-313.8K |
毛利率ENSCKOSS
| Q4 25 | — | 29.0% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 40.4% | ||
| Q1 24 | — | 31.9% |
营业利润率ENSCKOSS
| Q4 25 | -147.8% | -35.5% | ||
| Q3 25 | -758.7% | -1.1% | ||
| Q2 25 | -127.6% | -14.2% | ||
| Q1 25 | -149.1% | -18.7% | ||
| Q4 24 | -274.3% | -4.0% | ||
| Q3 24 | 18.9% | -19.9% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | -23.1% |
净利率ENSCKOSS
| Q4 25 | -147.0% | -19.8% | ||
| Q3 25 | -756.3% | 6.0% | ||
| Q2 25 | -126.4% | -7.5% | ||
| Q1 25 | -147.4% | -11.4% | ||
| Q4 24 | -273.4% | 2.6% | ||
| Q3 24 | 19.4% | -13.1% | ||
| Q2 24 | — | -3.8% | ||
| Q1 24 | — | -11.9% |
每股收益（稀释后）ENSCKOSS
| Q4 25 | $-0.51 | $-0.06 | ||
| Q3 25 | $-1.29 | $0.03 | ||
| Q2 25 | $-0.79 | $-0.02 | ||
| Q1 25 | $-1.39 | $-0.03 | ||
| Q4 24 | $-0.89 | $0.01 | ||
| Q3 24 | $1.00 | $-0.05 | ||
| Q2 24 | — | $-0.01 | ||
| Q1 24 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $15.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.2M | $30.3M |
| 总资产 | $7.5M | $36.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ENSCKOSS
| Q4 25 | $4.3M | $15.5M | ||
| Q3 25 | $1.7M | $16.5M | ||
| Q2 25 | $2.2M | $15.7M | ||
| Q1 25 | $3.1M | $13.0M | ||
| Q4 24 | $3.5M | $9.7M | ||
| Q3 24 | $4.2M | $11.9M | ||
| Q2 24 | — | $14.9M | ||
| Q1 24 | — | $9.9M |
股东权益ENSCKOSS
| Q4 25 | $3.2M | $30.3M | ||
| Q3 25 | $1.2M | $30.9M | ||
| Q2 25 | $3.4M | $30.6M | ||
| Q1 25 | $3.0M | $30.7M | ||
| Q4 24 | $3.7M | $31.0M | ||
| Q3 24 | $6.9M | $30.8M | ||
| Q2 24 | — | $31.1M | ||
| Q1 24 | — | $31.1M |
总资产ENSCKOSS
| Q4 25 | $7.5M | $36.8M | ||
| Q3 25 | $3.2M | $37.7M | ||
| Q2 25 | $5.6M | $37.2M | ||
| Q1 25 | $4.6M | $37.3M | ||
| Q4 24 | $5.6M | $37.4M | ||
| Q3 24 | $9.4M | $38.1M | ||
| Q2 24 | — | $37.2M | ||
| Q1 24 | — | $37.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $-760.8K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.1M |
| 自由现金流率自由现金流/营收 | — | -37.5% |
| 资本支出强度资本支出/营收 | — | 10.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-546.7K |
8季度趋势，按日历期对齐
经营现金流ENSCKOSS
| Q4 25 | $-1.5M | $-760.8K | ||
| Q3 25 | $-1.9M | $762.6K | ||
| Q2 25 | $-2.7M | $-534.9K | ||
| Q1 25 | $-1.7M | $370.4K | ||
| Q4 24 | $-764.1K | $-252.0K | ||
| Q3 24 | $-1.0M | $201.6K | ||
| Q2 24 | — | $-174.0K | ||
| Q1 24 | — | $328.6K |
自由现金流ENSCKOSS
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $761.5K | ||
| Q2 25 | — | $-541.8K | ||
| Q1 25 | — | $306.2K | ||
| Q4 24 | — | $-314.3K | ||
| Q3 24 | — | $-155.6K | ||
| Q2 24 | — | $-174.8K | ||
| Q1 24 | — | $269.3K |
自由现金流率ENSCKOSS
| Q4 25 | — | -37.5% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | -8.8% | ||
| Q3 24 | — | -4.9% | ||
| Q2 24 | — | -6.0% | ||
| Q1 24 | — | 10.2% |
资本支出强度ENSCKOSS
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.3% |
现金转化率ENSCKOSS
| Q4 25 | — | — | ||
| Q3 25 | — | 3.13× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.68× | ||
| Q3 24 | -1.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
